Prescription drug · ANDA
Lisinopril and Hydrochlorothiazide NDC 71610-274
Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-274-80 | 71610027480 | 180 TABLET in 1 BOTTLE, PLASTIC (71610-274-80)Marketed from May 6, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lisinopril and Hydrochlorothiazide
- Generic name (nonproprietary)
- lisinopril and hydrochlorothiazide
- Active ingredients
- Lisinopril — 20 mg/1Hydrochlorothiazide — 12.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076194
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
- Identifiers
- Product ID 71610-274_afec283e-075f-46b5-a927-00434373aa92SPL ID afec283e-075f-46b5-a927-00434373aa92SPL set ID 5eea66bd-589a-45f8-ba2c-dea66a939d59RxCUI 197886UNII E7199S1YWR, 0J48LPH2TH
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610027480followed by a unit qualifier and the quantityPackage 71610-0274-80. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Lisinopril and Hydrochlorothiazide Tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will requi…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 076194
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-414 |
| Lisinopril and Hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0862 |
| Lisinopril and Hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-4435 |
| Lisinopril and hydrochlorothiazide | Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | NuCarePharmaceuticals, Inc. | 68071-3008 |
| Lisinopril and Hydrochlorothiazide | Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Actavis Pharma, Inc. | 0591-0860 |
| Lisinopril and Hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Actavis Pharma, Inc. | 0591-0861 |
| Lisinopril and Hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Actavis Pharma, Inc. | 0591-0862 |
| Lisinopril and hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Proficient Rx LP | 63187-051 |
| Lisinopril and hydrochlorothiazide | Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Proficient Rx LP | 63187-050 |
| Lisinopril and Hydrochlorothiazide | Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | QPharma Inc | 42708-034 |